We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-2.17%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$520M
AUM Growth
-$27.7M
Cap. Flow
-$13.6M
Cap. Flow %
-2.62%
Top 10 Hldgs %
32.77%
Holding
158
New
6
Increased
21
Reduced
108
Closed
10

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.7M
2
MMM icon
3M
MMM
+$3.69M
3
DRC
DRESSER-RAND GROUP INC
DRC
+$3.31M
4
DO
Diamond Offshore Drilling
DO
+$2.88M
5
INTC icon
Intel
INTC
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.16%
2 Industrials 19.16%
3 Technology 17.92%
4 Energy 8.19%
5 Utilities 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMP icon
51
Tompkins Financial
TMP
$1.42B
$3.29M 0.63%
74,525
-2,825
-4% -$129K
ALTR
52
DELISTED
Altera Corp
ALTR
$3.15M 0.61%
88,150
+47,350
+116% +$1.65M
YAO
53
DELISTED
Invesco China All-Cap ETF
YAO
$3.05M 0.59%
113,544
-2,725
-2% -$76.8K
XRAY icon
54
Dentsply Sirona
XRAY
$2.84B
$3.04M 0.58%
66,675
-3,245
-5% -$153K
ADT
55
DELISTED
ADT Corp
ADT
$3.03M 0.58%
85,387
-4,975
-6% -$176K
EEMV icon
56
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.36B
$3.01M 0.58%
50,300
+38,900
+341% +$2.4M
CHL
57
DELISTED
China Mobile Limited
CHL
$2.73M 0.53%
46,500
-2,150
-4% -$124K
IXYS
58
DELISTED
IXYS Corp
IXYS
$2.72M 0.52%
+259,365
New +$3.05M
TYC
59
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$2.71M 0.52%
57,956
-990
-2% -$46.1K
OGE icon
60
OGE Energy
OGE
$9.87B
$2.59M 0.5%
69,700
-1,500
-2% -$55.2K
DLB icon
61
Dolby
DLB
$4.97B
$2.57M 0.49%
61,400
-4,170
-6% -$185K
HOLX
62
DELISTED
Hologic
HOLX
$2.5M 0.48%
102,850
-6,300
-6% -$159K
XBI icon
63
State Street SPDR S&P Biotech ETF
XBI
$10B
$2.41M 0.46%
46,371
-1,275
-3% -$65K
MON
64
DELISTED
Monsanto Co
MON
$2.3M 0.44%
20,410
-125
-0.6% -$14.6K
SR icon
65
Spire
SR
$4.79B
$2.25M 0.43%
48,600
-1,700
-3% -$81.6K
XYL icon
66
Xylem
XYL
$28.5B
$2.25M 0.43%
63,465
-1,505
-2% -$55.9K
LFCR icon
67
Lifecore Biomedical
LFCR
$162M
$2.19M 0.42%
178,600
-9,750
-5% -$122K
JPM icon
68
JPMorgan Chase
JPM
$916B
$2.1M 0.4%
34,849
-2,100
-6% -$123K
EWZ icon
69
iShares MSCI Brazil ETF
EWZ
$8.98B
$2.08M 0.4%
47,935
-1,300
-3% -$64.3K
ABT icon
70
Abbott
ABT
$187B
$2.07M 0.4%
49,697
-800
-2% -$33.8K
TEX icon
71
Terex
TEX
$7.37B
$2.04M 0.39%
64,200
+15,600
+32% +$570K
EPU icon
72
iShares MSCI Peru and Global Exposure ETF
EPU
$521M
$2.03M 0.39%
59,290
-4,670
-7% -$169K
EWA icon
73
iShares MSCI Australia ETF
EWA
$1.38B
$2.01M 0.39%
83,825
-1,475
-2% -$38.8K
NEOG icon
74
Neogen
NEOG
$2.05B
$1.98M 0.38%
133,461
-1,134
-0.8% -$17.9K
LXFR icon
75
Luxfer Holdings
LXFR
$456M
$1.97M 0.38%
114,385
+5,085
+5% +$94K

Similar funds

John G. Ullman & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, John G. Ullman & Associates held 158 positions worth $520M, down 5.1% from $548M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2014 filing shows 6 new, 21 increased, 108 reduced and 10 closed positions. Its largest new stake was CYTEC INDS INC: 74,750 shares worth $3.54M. The largest sale was Microsoft, an estimated $4.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q3 2014 buy was CYTEC INDS INC: 74,750 shares worth $3.54M.
  • John G. Ullman & Associates added most to iShares MSCI Emerging Markets Min Vol Factor ETF in Q3 2014, an estimated $2.4M increase.
  • John G. Ullman & Associates's biggest Q3 2014 reduction was Microsoft, cutting an estimated $4.7M.
  • John G. Ullman & Associates fully exited Diamond Offshore Drilling in Q3 2014, selling an estimated $2.88M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $520M portfolio in Q3 2014.
  • John G. Ullman & Associates opened 6 new positions and closed 10 in Q3 2014.
  • John G. Ullman & Associates's portfolio value fell 5.1% quarter-over-quarter to $520M.

Based on John G. Ullman & Associates's 13F filing for Q3 2014, filed 12 Nov 2014.